A Study of ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B (CHB)

NCT02797522 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

47

Enrollment

INDUSTRY

Sponsor class

Stopped Company decision to discontinue trial

Conditions

Hepatitis B

Interventions

DRUG: ARC-521 Injection
OTHER: Placebo
DRUG: antihistamine
DRUG: acetaminophen
DRUG: entecavir
DRUG: tenofovir

Sponsor

Arrowhead Pharmaceuticals